Parkinson’s disease is normally a chronic and progressive movement disorder that there presently is no cure. It involves the death and malfunction of essential nerve cells in the brain, called neurons. A few of these dying neurons produce dopamine, a chemical substance that sends text messages to the right area of the brain that controls movement and coordination. As PD progresses, the amount of dopamine created in the mind decreases, leaving a person struggling to normally control movement. One million people in the United States have PD currently, in fact it is estimated that seven to 10 million people around the global world have problems with the disease. PDF and the AAN Basis collaborate through this award to ensure up-and-coming scientists focused on enhancing the lives of individuals coping with Parkinson’s have the tools to do so, stated James Beck, PhD, Director of Research Programs at PDF.This study provides the strongest findings to date to suggest that vitamin D could be protective against type 1 diabetes. In type 1 diabetes , the body's disease fighting capability episodes and permanently disables the insulin-building cells in the pancreas. About 5 percent of the approximated 25.8 million people in the United States with diabetes possess type 1, according to the American Diabetes Association. Though it starts in childhood often, about 60 percent of type 1 diabetes instances occur after age 20. Earlier studies have suggested a shortage of vitamin D may improve type 1 diabetes risk, although those studies mainly examined the hyperlink between vitamin D levels in pregnancy or childhood and the risk of type 1 diabetes in children. Other research, in young adults, uncovered a link between high supplement D levels and a lowered threat of multiple sclerosis-an autoimmune disease genetically and epidemiologically linked to type 1 diabetes-suggesting that inadequate supplement D in adulthood could be an important risk element for autoimmune diseases in general.